High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.

BACKGROUND In the clinic, the combination of obesity and chronic obstructive pulmonary disease (COPD) has been increasing. However, whether high body mass index (BMI) affects the risk of exacerbations and pneumonias in individuals with COPD is presently unknown. Genetics can be used to assess the causal role of high BMI in exacerbations and pneumonias in individuals with COPD. We tested the hypothesis that high BMI is associated with an increased risk of exacerbations and pneumonias in individuals with COPD, both observationally and genetically. METHODS We genotyped 93 894 individuals of Danish descent, aged 20-100 years, from the Copenhagen General Population Study, for FTO (rs9939609), MC4R (rs17782313) and TMEM18 (rs6548238), and created an allele score. A total of 10 883 individuals had spirometric COPD with forced expiratory volume in 1 s (FEV1) / forced vital capacity (FVC) < lower limit of normal (LLN). In these individuals, we observed 1453 exacerbations and 3390 pneumonias during 4.7 years of follow-up. RESULTS For each increase in allele score, BMI was 0.28 kg/m2 [95% confidence interval (CI): 0.25-0.30) higher. Age- and sex-adjusted genetic hazard ratios (HRs) per one allele score increase in individuals with COPD were 1.13 (1.01-1.27) for exacerbations, 1.10 (1.03-1.19) for pneumonias and 1.12 (1.04-1.21) for exacerbations and/or pneumonias. Corresponding multivariable adjusted observational HRs per unit (kg/m2) BMI increase were 0.98 (0.95-1.01), 0.99 (0.96-1.03) and 0.99 (0.96-1.01), respectively. CONCLUSIONS Genetically determined high BMI was associated with an increased risk of recurrent exacerbations and pneumonias in individuals with COPD, whereas this was not the case for observationally determined high BMI. The genetic data are compatible with the notion that high BMI leads to increased risk of exacerbations and pneumonias in individuals with COPD.

[1]  R. Gill,et al.  Cox's regression model for counting processes: a large sample study : (preprint) , 1982 .

[2]  B. Make,et al.  Physical Activity, Health Status and Risk of Hospitalization in Patients with Severe Chronic Obstructive Pulmonary Disease , 2010, Respiration.

[3]  P. Lange,et al.  Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. , 2011, Respiratory medicine.

[4]  B. Nordestgaard,et al.  Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[5]  T. Frayling,et al.  C-reactive protein levels and body mass index: Elucidating direction of causation through reciprocal Mendelian randomization , 2010, International Journal of Obesity.

[6]  John B Carlin,et al.  Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. , 2010, American journal of epidemiology.

[7]  N. Vozoris,et al.  Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. , 2012, Canadian respiratory journal.

[8]  E. Wouters,et al.  Influence of diet and obesity on COPD development and outcomes , 2014, International journal of chronic obstructive pulmonary disease.

[9]  Henrik,et al.  Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index , 2012 .

[10]  A. Sood.  Pulmonary Physiology and Pathophysiology in Obesity Obesity , adipokines , and lung disease , 2010 .

[11]  D. Pierson,et al.  Obesity and COPD: Associated Symptoms, Health-related Quality of Life, and Medication Use , 2011, COPD.

[12]  S. Kon,et al.  Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation , 2014, Thorax.

[13]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[14]  B. Nordestgaard,et al.  Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. , 2011, European heart journal.

[15]  B. Nordestgaard,et al.  New Danish reference values for spirometry , 2013, The clinical respiratory journal.

[16]  S. Stanojevic,et al.  Recommendations for epidemiological studies on COPD , 2012, European Respiratory Journal.

[17]  F. Franssen,et al.  Obesity and the lung: 5 · Obesity and COPD , 2008, Thorax.

[18]  N. Timpson,et al.  The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach , 2012, PLoS medicine.

[19]  Ciro Casanova,et al.  Prediction of risk of COPD exacerbations by the BODE index. , 2009, Respiratory medicine.

[20]  Arul Earnest,et al.  A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. , 2005, Chest.

[21]  Abdullah Al Mamun,et al.  Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis , 2003, Annals of Internal Medicine.

[22]  D. Jarvis,et al.  Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. , 2007, American journal of respiratory and critical care medicine.

[23]  S. Bojesen,et al.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[24]  Christian Gieger,et al.  The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis , 2013, BDJ.

[25]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[26]  S. Bojesen,et al.  Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts , 2014, BMJ : British Medical Journal.

[27]  B. Nordestgaard,et al.  Antihypertensive treatment and risk of atrial fibrillation: a nationwide study. , 2014, European heart journal.

[28]  J. Vestbo,et al.  Validation of the i-BODE Index as a Predictor of hospitalization and Mortality in Patients with COPD Participating in Pulmonary Rehabilitation , 2014, COPD.

[29]  B. Nordestgaard,et al.  Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. , 2013, JAMA.